Educational Activities

Certified Activity
Non-certified Activity
Resource
Patient Education
Expired Activity

1-6 of 343 Activities

Title
Availability
Format
Credits
Launch Date
Buttons
Buttons
On-Demand
CME Snack
1.0
11/06/2024

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Demystified: From Symptoms to Solutions

In this CME Outfitters Snack, expert faculty will address the impact of CIDP and common challenges the multidisciplinary healthcare team faces, including disease burden and pathophysiology, guideline best practices for diagnosis and treatment, and emerging biologic treatments.

1.0
11/06/2024

Amy Perrin Ross, APN, MSN, CNRN, MSCN

Amy Perrin Ross, APN, MSN, CNRN, MSCN

Jaimie Rose Sheil

Jaimie Rose Sheil

Niraja Suresh, MD

Niraja Suresh, MD

Richard A. Lewis, MD

Richard A. Lewis, MD

Buttons
On-Demand
Webcast
1.5
11/04/2024

What’s IL-23 Got to Do With It? Targeted Therapies in the Management of IBD

In this CME Outfitters recorded symposium, expert faculty will review the functions of Fc gamma receptors, CD64 and its connection with IL-23, the molecular attributes of anti–IL-23 therapies, in vivo data on expression of CD64 monocytes, and the most recent clinical trial data differentiating the anti–IL-23 agents. To demonstrate these concepts, animated 3-D models will be included in the educational program and available to attendees.

1.5
11/04/2024

Corey A. Siegel, MD, MS

Corey A. Siegel, MD, MS

Moderator

David P. Hudesman, MD, FACG, AGAF

David P. Hudesman, MD, FACG, AGAF

Marla Dubinsky, MD

Marla Dubinsky, MD

Moderator

Buttons
On-Demand
Webcast
1.5
11/04/2024

How Low Can You Go? Targeting of Deep Remission in the Management of Crohn’s Disease

In this CME Outfitters recorded symposium, expert faculty will guide learners on how to integrate knowledge of the heterogeneity of CD in severity and manifestation into patient assessment and treatment. Learners will be instructed on utilizing alternative diagnostic and evaluation tools beyond colonoscopy for evaluating symptoms in patients with CD. Faculty will model incorporation of histopathologic treatment targets as an objective measure of inflammation in CD to inform clinical decision-making. 

1.5
11/04/2024

Bruce E. Sands, MD, MS

Bruce E. Sands, MD, MS

Moderator

Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN

Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN

Millie D. Long, MD, MPH

Millie D. Long, MD, MPH

Buttons
On-Demand
Podcast
0.5
10/31/2024

Expanding Options for Immune Checkpoint Inhibitors in Front-Line Advanced/Recurrent Endometrial Cancer

In the third activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on treatment of endometrial cancer, including strategies that utilize molecular testing and ICI therapies.

0.5
10/31/2024

Jonathan Ledermann, MD, FRCP, FMedSci

Jonathan Ledermann, MD, FRCP, FMedSci

Richard T. Penson, MD, MRCP

Richard T. Penson, MD, MRCP

Moderator

Buttons
On-Demand
Briefcase
0.75
10/24/2024

Managing Migraine in Primary Care and Women’s Health Practice Settings

Given the recent position statement from the American Headache Society endorsing calcitonin gene-related peptide receptor antagonists (CGRP-RAs) for first-line prevention of migraine, it is crucial for primary care practitioners to ensure all patients have access to the latest, evidence-based treatments. In this activity, expert faculty will address the educational needs of non-migraine specialist healthcare practitioners. We will discuss common challenges faced by the multidisciplinary care team, including shared decision-making practices to determine the best treatment options for patients. 

0.75
10/24/2024

Jessica Ailani, MD, FAHS, FAAN

Jessica Ailani, MD, FAHS, FAAN

Moderator

Susan L. Hutchinson, MD

Susan L. Hutchinson, MD

Buttons
On-Demand
Webcast
1.5
10/22/2024

Addressing Barriers in Advancing Equitable Biomarker Testing in Community Oncology

In this CME Outfitters recorded symposium expert faculty will evaluate the latest biomarker testing strategies in prostate, bladder, and lung cancer, discussing how to integrate all members of the interdisciplinary care team in community oncology settings, identifying root causes of health inequity in cancer care and how to incorporate strategies to address unconscious bias and provide the latest biomarker testing services in cancer care management. 

1.5
10/22/2024

Zach Rivers, PharmD, PhD

Zach Rivers, PharmD, PhD

Dusty Donaldson

Dusty Donaldson

Diana Brixner, BPharm, PhD, FAMCP

Diana Brixner, BPharm, PhD, FAMCP

Moderator